Evidence map›Paper›PMID 21876032›Full record

ReviewJournal of dental research2012

Cigarette smoking and inflammation: cellular and molecular mechanisms.

J Lee, V Taneja, R Vassallo

Abstract readReview
In one paragraph

Review in Journal of dental research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 371 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
371citing papers in PubMed, 3 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

371 citing papers in PubMed, 3 syntheses or guidelines pooled it, 663 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

311 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J LeeDepartment of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
V Taneja
R Vassallo
Mayo Clinic · US

Funding

Impact of smoking on immune response and arthritis in humanized miceR21AR060077 · NIAMS · MAYO CLINIC ROCHESTER · PI TANEJA, VEENA · 2010 to 2011
$379k
Interleukin-17 mediated inflammation in COPDR03HL096829 · NHLBI · MAYO CLINIC ROCHESTER · PI VASSALLO, ROBERT · 2009 to 2010
$151k
NHLBI NIH HHS HL96829ZNHLBI NIH HHS R03 HL096829NIAMS NIH HHS AR60077NIAMS NIH HHS R21 AR060077
6 · The paper itself

Abstract

Cigarette smoke (CS) causes considerable morbidity and mortality by inducing cancer, chronic lung and vascular diseases, and oral disease. Despite the well-recognized risks associated with smoking, the habit remains unacceptably prevalent. Several toxins present in CS have immunomodulatory effects. CS also contains trace amounts of microbial cell components, including bacterial lipopolysaccharide. These and other CS constituents induce chronic inflammation at mucosal surfaces and modify host responses to exogenous antigens. The effects of CS on immunity are far-reaching and complex; both pro-inflammatory and suppressive effects may be induced. The net effect of CS on immunity depends on many variables, including the dose and type of tobacco, the route and chronicity of exposure, and the presence of other factors at the time of immune cell stimulation, such as Toll receptor ligands or other inflammatory mediators. CS impairs innate defenses against pathogens, modulates antigen presentation, and promotes autoimmunity. CS also impairs immunity in the oral cavity and promotes gingival and periodontal disease and oral cancer. The recognition of specific mechanisms by which CS affects host immunity is an important step toward elucidating mechanisms of tobacco-induced disease and may identify novel therapeutic approaches for the management of diseases that afflict smokers.

Indexed as

Antigen PresentationAutoimmunityComplex MixturesHumansImmunity, MucosalImmunologic FactorsImmunosuppressive AgentsInflammationInflammation MediatorsMouth DiseasesMouth NeoplasmsPeriodontal DiseasesSmokingToxins, BiologicalComplex MixturesImmunologic FactorsImmunosuppressive AgentsInflammation MediatorsToxins, Biological

Identifiers

PMID21876032
PMCPMC3261116
OpenAlexW2151633680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.